Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma

Clinical trial NCT00441818 · UNKNOWN

Trial details

NCT number: NCT00441818
Sponsor: Tanox
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hodgkin's Lymphoma

Start date: 2006-05-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.